Electronic health record best practice advisory
Electronic health record best practice advisory has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Nov 2, 2026: “Impact of an Electronic Health Record Best Practice Advisory on Lipoprotein(a) Testing and Downstream Lipid Management”.
1 paper studies it3 findingsUpdated
1 new paper in 30 daysSee all 1 papers on electronic health record best practice advisory
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“BPA exposure was strongly associated with Lp(a) testing (adjusted OR: 22.86; 95% CI: 17.26-30.27; p<0.001).”
None of its findings points the other way.
- 1 lab in 1 country
- 3 of 3 findings with company ties
- Humans1
What is electronic health record best practice advisory linked with?
3Studies link electronic health record best practice advisory with 3 measures: LDL-C goal achievement, Lipid-lowering therapy initiation and Lipoprotein(a) testing.
LDL-C goal achievement
upin humans1
1 study
LDL-C goal achievement
upin humans1
Electronic health record best practice advisory is associated with LDL-C goal achievement in humans (LDL-C <55 mg/dL; compared with matched controls) (11.3% vs. 5.2%, p=0.03).
“LDL-C goal achievement was higher in the BPA group for LDL-C <70 mg/dL (22.6% vs. 15.3%, p=0.08) and LDL-C <55 mg/dL (11.3% vs. 5.2%, p=0.03).”
Human trialLDL-C <55 mg/dL; compared with matched controlsEHR-based12 months
AHA Scientific Sessions 2026 abstract
Lipid-lowering therapy initiation
upin humans1OR 1.49
1 study
Lipid-lowering therapy initiation
upin humans1OR 1.49
Electronic health record best practice advisory is associated with lipid-lowering therapy initiation in humans (clinically eligible patients; compared with matched controls) (7.9% vs. 6.0%; adjusted OR 1.49, 95% CI 1.00–2.22).
“BPA-exposed patients also had a trend for higher initiation rates of any lipid-lowering therapy (7.9% vs. 6.0%)”
Human trialclinically eligible patients; compared with matched controlsEHR-based12 months
AHA Scientific Sessions 2026 abstract
Lipoprotein(a) testing
upin humans1OR 22.86
1 study
Lipoprotein(a) testing
upin humans1OR 22.86
Electronic health record best practice advisory is associated with lipoprotein(a) testing in humans (clinically eligible patients; compared with matched controls) (46.1% vs. 3.8%; adjusted OR 22.86, 95% CI 17.26–30.27).
“BPA exposure was strongly associated with Lp(a) testing (adjusted OR: 22.86; 95% CI: 17.26-30.27; p<0.001).”
Human trialclinically eligible patients; compared with matched controlsEHR-based12 months
AHA Scientific Sessions 2026 abstract